BD completes takeover of Cellular Research

BD has announced the completion of its acquisition of collaborative partner Cellular Research.

The move will lay the foundations for the company's future efforts to create a leading genomics platform for single-cell analysis. Additional terms of the agreement, including financial details, were not disclosed.

Since September 2014, BD and Cellular Research have collaborated to develop single-cell analysis workflows for Cellular Research's Precise product line and BD's FACS instruments and software.

BD and Cellular Research's combined capabilities will provide researchers with an integrated sample prep workflow to quantify and study gene expression in large numbers of individual cells, enabling higher-resolution biology.

Linda Tharby, executive vice-president and president of BD Life Sciences, said: "The addition of Cellular Research builds on our GenCell acquisition and underscores BD's commitment to a genomics strategy focused on next-generation sequencing sample preparation."

This follows the company's acquisition of CRISI Medical Systems earlier this year.